Searchable abstracts of presentations at key conferences in endocrinology

ea0030oc2.2 | Oral Communications 2 | BSPED2012

Deficiency of the triple A syndrome gene product, ALADIN, renders human adrenal cells susceptible to oxidative stress with subsequent impact on steroidogenesis

Prasad Rathi , Clark Adrian , Storr Helen

Background: Triple A syndrome is a rare, autosomal recessive cause of adrenal insufficiency. Additional features include alacrima, achalasia of the oesophageal cardia, and neurodegenerative disease in 60%. The AAAS gene product is the nuclear pore complex protein ALADIN of unknown function. AAAS patient dermal fibroblasts have been described as hypersensitive to oxidative stress1,2,3.Objective: To establish a better disease model by kno...

ea0028p310 | Steroids | SFEBES2012

Oxidative stress in the pathogenesis of triple a syndrome

Prasad Rathi , Clark Adrian , Storr Helen

Background: Triple A Syndrome is a rare, autosomal recessive cause of adrenal failure that usually manifests in the first decade. Most cases have isolated glucocorticoid deficiency, but this is accompanied by mineralocorticoid deficiency in approximately 10% of cases. Additional features include alacrima (~90%), achalasia of the oesophageal cardia (~75%), and a progressive neurodegenerative process (~60%). The AAAS gene product is the nuclear pore complex protein ALADIN...

ea0027p31 | (1) | BSPED2011

Oxidative stress in the pathogenesis of Triple A syndrome

Prasad Rathi , Clark Adrian , Storr Helen

Introduction: Triple A syndrome is a rare, autosomal recessive cause of adrenal failure that usually manifests in the first decade. Most cases have isolated glucocorticoid deficiency, but this is accompanied by mineralocorticoid deficiency in ~10%. Additional features include alacrima (~90%), achalasia of the oesophageal cardia (~75%), and a progressive neurodegenerative process (~60%). The AAAS gene product is the nuclear pore complex protein ALADIN of unknown function...

ea0021p146 | Diabetes and metabolism | SFEBES2009

Regulation of the melanocortin receptor accessory protein (MRAP) in Y1 adrenal cells

Siddiq Imran , Chung Teng-Teng , Clark Adrian

Melanocortin receptor accessory protein (MRAP) is a single transmembrane domain protein, which has been identified as essential for the cell surface trafficking and signalling of the ACTH receptor (melanocortin 2 receptor (MC2R)). MRAP is essential for the function of MC2R, but regulation of its expression remains unclear. This study aims to identify factors regulating MRAP gene expression and whether these factors would affect the signalling of MC2R.The...

ea0021p336 | Steroids | SFEBES2009

Post-traumatic hypoadrenalism case report

Deshpande Sarika , Wijenaike Nishan , Clark John

Direct trauma to the adrenal glands resulting in adrenal gland failure is relatively rare. We present two cases of post-traumatic hypoadrenalism.Case 1: A 53-year-old male who was trapped under a lorry trailer. He was found to have fractures of T6 (unstable), T12, rib and sternal fractures. He was transferred to the orthopaedic ward and required a spinal splint. He was slowly recovering until day 20 of his admission when he became hypotensive and tachyca...

ea0021p361 | Steroids | SFEBES2009

Anti-inflammatory effects of SGRMs: are they dependent on DUSP1?

Joanny Eugenie , Martins Joana , Clark Andrew

Glucocorticoids (GCs) are steroid hormones, products of the hypothalamic–pituitary–adrenal axis. Synthetic GCs, such as dexamethasone, have been widely used in the treatment of inflammatory diseases like rheumatoid arthritis or asthma, but their long-term use causes severe side effects (osteoporosis, diabetes, hypertension, etc). The ligand-bound GC receptor (GR) can activate gene expression via binding to GC response elements (GREs), a mechanism known as transactiva...

ea0020s3.2 | Genetics in neuroendocrinology | ECE2009

ACTH insensitivity syndromes

Clark Adrian , Hughes Claire , Metherell Louise

ACTH insensitivity or familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder first described in 1959. We demonstrated in 1993 that about 25% of affected patients have nonsense or (more commonly) missense mutations in the ACTH receptor (melanocoprtin 2 receptor, MC2R). Functional analysis of these mutations had been especially difficult until our discovery in 2005 that the receptor requires an essential accessory factor – the melanocortin 2 recepto...

ea0015p219 | Pituitary | SFEBES2008

Low dose cabergoline in hyperprolactinaemia is not associated with clinically significant valvular heart disease

Wakil Ammar , Clark Andrew , Atkin Stephen

Introduction: Recent trials suggest that using ergot-derived dopamine agonists such as cabergoline in the treatment of Parkinson’s disease is associated with an increased risk of valvular heart disease. However, the dose of cabergoline used to treat hyperprolactinaemia is considerably less than that used in Parkinson’s disease.Study design: A cross-sectional study; forty four patients, who received cabergoline for at least 6 months, underwent t...

ea0009p131 | Steroids | BES2005

Identification of the sites of expression of the Triple A syndrome mRNA in the rat using in situ hybridisation

Storr H , Clark A , Priesley J , Michael G

Triple A syndrome is is a rare autosomal recessive disorder characterised by achalasia, alacrima, adrenocorticotropin-resistant adrenal insufficiency and a variable and progressive neurological phenotype. The AAAS gene encodes a 60kD WD-repeat nuclear pore protein named ALADIN (alacrima, achalasia, adrenal insufficiency neurologic disorder); its function and tissue distribution are unknown. In this study we performed in situ hybridization with 35S end-labelled AAAS mRNA oligon...

ea0004s25 | Journal of Endocrinology Symposium: Young Innovations - Society for Endocrinology Research Fellows Update | SFE2002

Methylation of the POMC gene

Newell-price J , King P , Clark A

Ectopic secretion of adrenocorticotropin (ACTH), from sites such as small cell lung cancer (SCLC), results in severe Cushing's syndrome. ACTH is cleaved from pro-opiomelanocortin (POMC). The syndrome occurs when the highly tissue-specific promoter of POMC is activated. This promoter lies within a defined CpG island. CpG islands are usually considered to be unmethylated in all tissues. We hypothesised that changes in promoter DNA methylation might direct aberrant express...